Dose-dependent L-dopa/carbidopa-induced hyponatremia presenting with hiccups

Levodopa (L-dopa) is the most effective antiparkinsonian agent and is well tolerated at all stages of the disease. However, both motor and nonmotor adverse events are reported with the use of L-dopa. Electrolyte imbalances such as hyponatremia and hiccups with L-dopa/carbidopa are very rare. For the...

Full description

Saved in:
Bibliographic Details
Published inJournal of family medicine and primary care Vol. 9; no. 3; pp. 1749 - 1751
Main Authors Shihabudheen, P, Anver, P, Uvais, N, Mohammed, T
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer India Pvt. Ltd 01.03.2020
Medknow Publications and Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects
adverse events
Antiparkinson agents
Aripiprazole
Case Report
Complications and side effects
Diseases
Dosage and administration
Electrolytes
Entacapone
hiccups
Hyponatremia
L-dopa
l-dopa/carbidopa
Phenols (Class of compounds)
Pramipexole
Sulbactam
Telmisartan
Time
Tolvaptan
hiccups
L-dopa/carbidopa
Adverse events
hyponatremia
Online AccessGet full text

Cover

More Information
Summary:Levodopa (L-dopa) is the most effective antiparkinsonian agent and is well tolerated at all stages of the disease. However, both motor and nonmotor adverse events are reported with the use of L-dopa. Electrolyte imbalances such as hyponatremia and hiccups with L-dopa/carbidopa are very rare. For the first time, we are reporting a case of L-dopa/carbidopa-induced hyponatremia and hiccup cooccurring in a 75-year-old male. He symptomatically improved after reducing the dose of levodopa/carbidopa, indicating a dose-dependent nature of these adverse events. Clinicians who prescribe L-dopa/carbidopa should be mindful of the potential for precipitating SIADH and hiccups, especially in elderly patients.
ISSN:2249-4863
2278-7135
DOI:10.4103/jfmpc.jfmpc_1044_19